On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...